![](https://s3.pgkb.org/pathway/PA166121347.png?versionId=zFzLwnA_QjqGwtLTD0V2LjnkEyYFua8Y)


# Hypothesis

1. * Paroxitine strongly inhibits CYP2D6 https://pubmed.ncbi.nlm.nih.gov/9817620/
2. * CYP2D6 Is Functional in Human Brain In Vivo https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383223/
3. * astroglial cells are implicated in ASD  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583956/#:~:text=There%20are%20some%20clinical%20reports,of%20these%20cells%20%5B5%5D.
4. * CYP2D6 is expressed in glial cells https://www.tandfonline.com/doi/full/10.1080/03602532.2020.1858856
5. * Paroxitine passes from mother to fetus https://pubmed.ncbi.nlm.nih.gov/30105921/
6. * Our result that Paroxitine has a strong protective effect.


# SSRI impact

## CYP2D6

+ Fluvoxamine Moderate_Inhibitor https://pubmed.ncbi.nlm.nih.gov/11876575/
+ Fluoxetine Strong_Inhibitor https://pubmed.ncbi.nlm.nih.gov/11876575/ Long-lasting_inhibition
+ Paroxetine Strong_Inhibitor https://pubmed.ncbi.nlm.nih.gov/11876575/
+ Sertraline Moderate_Inhibitor https://pubmed.ncbi.nlm.nih.gov/11876575/
+ Citalopram No_Inhibition https://pubmed.ncbi.nlm.nih.gov/11876575/ OR Moderate_Inhibitor https://pubmed.ncbi.nlm.nih.gov/9068931/
+ 

